-

Rockwell Medical to Release Second Quarter 2025 Results on Thursday, August 14, 2025

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second quarter ended June 30, 2025 on Thursday, August 14, 2025. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET.

$RMTI to release its Q2'25 financial and operational results on Thursday, August 14, 2025.

Share

CONFERENCE CALL AND WEBCAST DETAILS

Date: Thursday, August 14, 2025

Time: 8:00am ET

Live Number: (888) 660-6347 // (International) 1 (929) 201-6594

Conference Call ID: 4944610

Webcast and Replay: www.RockwellMed.com/Results

Speakers:

  • Mark Strobeck, Ph.D. — President and Chief Executive Officer; and
  • Jesse Neri — SVP, Chief Financial Officer
  • Tim Chole — SVP, Chief Commercial Officer

Format: Discussion of second quarter 2025 financial and operational results followed by Q&A.

About Rockwell Medical

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is typically performed at freestanding outpatient dialysis centers, hospital-based outpatient centers, skilled nursing facilities, or in a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work® in 2023, 2024 and 2025, and named Fortune Best Workplaces in Manufacturing & ProductionTM in 2024, Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis SolutionsTM. For more information, visit www.rockwellmed.com.

Contacts

Heather R. Hunter
SVP, Chief Corporate Affairs Officer
(248) 432-1362
IR@RockwellMed.com

Rockwell Medical

NASDAQ:RMTI
Details
Headquarters: Wixom, MI
CEO: Mark Strobeck
Employees: 250
Organization: PUB
Revenues: 83,600,000 (2023)

Release Summary
Rockwell Medical will release its results for the second quarter ended June 30, 2025 on Thursday, August 14, 2025.
Release Versions
$Cashtags

Contacts

Heather R. Hunter
SVP, Chief Corporate Affairs Officer
(248) 432-1362
IR@RockwellMed.com

Social Media Profiles
More News From Rockwell Medical

Rockwell Medical Appoints Joe Dawson to the Company's Board of Directors

WIXOM, Mich.--(BUSINESS WIRE)--Joe Dawson is a seasoned executive who has extensive operational experience and a strong network in the renal care space....

Rockwell Medical Announces Third Quarter 2025 Results

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical achieved profitability on an Adjusted EBITDA basis for the third quarter 2025....

Rockwell Medical Names Rashad Brown Vice President, Manufacturing and Supply Chain

WIXOM, Mich.--(BUSINESS WIRE)--Mr. Brown has built a distinguished career leading complex manufacturing and supply chain organizations....
Back to Newsroom